CDER’s Quality Management Maturity Program
2022 Public Workshop
The FDA is developing a program to assess and rate the quality management maturity (QMM) of facilities manufacturing drug products and active pharmaceutical ingredients. A successful QMM rating program will improve supply chain transparency, inform purchasing decisions, reduce drug shortages, and increase medicine availability.
Tuesday, May 24, 2022
3:20 pm – 3:35 pm - QMM Foreign Pilot: Participant Perspective
(Eastern - EDT UTC-4)
You might be interested in: